5 High-Growth Micro-Cap Stocks to Buy Now

Page 1 of 5

In this article, we will list the 5 High-Growth Micro-Cap Stocks to Buy Now. Please visit 12 High-Growth Micro-Cap Stocks to Buy Now if you would like to see the extended list and the methodology behind it.

5. Niagen Bioscience Inc. (NASDAQ:NAGE)

Market Capitalization: $277.16 Million

Expected 5-Year Earnings Growth: 28.06%

Number of Hedge Fund Holders: 15

Stock Upside Potential: 226.09%

Niagen Bioscience Inc. (NASDAQ:NAGE) is one of the high-growth micro-cap stocks to buy now. On June 2, Niagen Bioscience Inc. (NASDAQ:NAGE) renamed the ChromaDex External Research Program (CERP) to the Niagen Research Program to underscore its renewed focus on advancing the understanding and applications of NAD+.

5 High-Growth Micro-Cap Stocks to Buy Now

Over the years, the company has focused on building a scientific foundation for NAD+ research through rigorous collaboration with leading independent investigators. Independent investigators from world-renowned institutions such as Mayo Clinic, the National Institutes of Health, and Cambridge University have repeatedly requested Niagen for its preclinical research and NAD+ biology.

Research under the program continues to explore NAD+ and Niagen across various areas of skeletal and brain tissues, cellular energy metabolism, and cardiovascular health. The program also supports more than 175 ongoing and developing research studies. It also provides oral Niagen research materials, including food-grade and pharmaceutical-grade products, as well as technical support.

Niagen Bioscience Inc. (NASDAQ:NAGE) is a global bioscience company focused on healthy aging and cellular health research. They are the innovators and patent holders of Niagen (nicotinamide riboside, or NR), a breakthrough ingredient clinically proven to boost NAD+ levels and support DNA repair and mitochondrial function.

Page 1 of 5
1281292 - 11759070 - 1